Astellas Pharma's first digital app and device combination product, DIGITIVA, was recently listed with the FDA in September '24. DIGITIVA is a comprehensive, non-invasive digital health solution for the management of heart failure that combines a digital stethoscope, an easy-to-use mobile app, and a dedicated clinical review team.  DIGITIVA also offers support to promote, track, and encourage healthy choices that may reduce the risk of, or help individuals to live well with, their heart failure.